arrow
A

Ateş Kara

hacettepe university
H指数:30
被引数:3,375

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pediatric invasive meningococcal disease in Türkiye during the post-pandemic period: increased reported cases and predominance of serogroup B and severity determined by a clinical form in a multicenter hospital-based cohort

后疫情时期土耳其儿童侵袭性脑膜炎球菌病:报告病例增加、B群血清型占主导地位以及临床分型决定严重程度的基于多中心医院的队列研究

2026-09-280
PRE
Influenza-associated neurological complications in pediatric patients: clinical characteristics, outcomes, and the neuroinfluenza severity score in the multicenter TURK-INF study

流感相关神经系统并发症在儿科患者中的临床特征、预后及神经流感严重程度评分在多中心TURK-INF研究中的应用

2026-09-150
PRE
Dual-antigen AdV5 vaccines against Crimean-Congo hemorrhagic fever virus induce superior humoral and Th1-biased cellular immunity

AdV5载体双抗原疫苗可诱导更优的体液和Th1偏向的细胞免疫以对抗克里米亚-刚果出血热病毒

2026-09-110
OAAI
Adverse Events in Following Immunization with Inactivated SARS-CoV-2 Vaccines (TURKOVAC and CoronaVac) in PCR-Positive Asymptomatic or Mildly Symptomatic Individuals Compared to PCR-Negative Recipients

接种灭活SARS-CoV-2疫苗(TURKOVAC和CoronaVac)后,PCR阳性无症状或轻度症状个体与PCR阴性接种者的不良事件比较

2026-07-290
OA
Seroprevalence of Hand, Foot and Mouth Disease Among Children and Adolescents in Türkiye

手足口病在土耳其儿童和青少年中的血清流行率

2026-05-250
OAAI
Infectious complications in pediatric acute lymphoblastic leukemia treatment: A comparison of ALL-IC BFM 2009 vs. modified St. Jude total XV in a single-center retrospective cohort study

儿童急性淋巴细胞白血病治疗中的感染并发症:ALL-IC BFM 2009与改良St. Jude total XV在单中心回顾性队列研究中的比较

2025-11-010
PRE
Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months

接种灭活SARS-CoV-2疫苗TURKOVAC可诱导持续长达8个月的体液和细胞免疫应答。

2025-04-280
OA
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccines

既往SARS-CoV-2感染对接种TURKOVAC或CoronaVac灭活新型冠状病毒肺炎疫苗个体的疫苗后不良事件的影响

2024-06-260
OAAI
Evaluation of 601 children with multisystem inflammatory syndrome (Turk MISC study)
2023-10-025
PRE
Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study
2023-07-121
OAAI
A snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey
2023-05-042
OAAI
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Turkey: A randomized trial
2022-10-317
OAAI